FR2034539A1 - - Google Patents

Info

Publication number
FR2034539A1
FR2034539A1 FR7004743A FR7004743A FR2034539A1 FR 2034539 A1 FR2034539 A1 FR 2034539A1 FR 7004743 A FR7004743 A FR 7004743A FR 7004743 A FR7004743 A FR 7004743A FR 2034539 A1 FR2034539 A1 FR 2034539A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7004743A
Other languages
French (fr)
Other versions
FR2034539B1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes de Produits Chimiques SA
Original Assignee
Societe dEtudes de Produits Chimiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dEtudes de Produits Chimiques SA filed Critical Societe dEtudes de Produits Chimiques SA
Publication of FR2034539A1 publication Critical patent/FR2034539A1/fr
Application granted granted Critical
Publication of FR2034539B1 publication Critical patent/FR2034539B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7004743A 1969-02-12 1970-02-11 Expired FR2034539B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7489/69A GB1236531A (en) 1969-02-12 1969-02-12 Adenin derivative

Publications (2)

Publication Number Publication Date
FR2034539A1 true FR2034539A1 (es) 1970-12-11
FR2034539B1 FR2034539B1 (es) 1974-08-09

Family

ID=9834107

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7004743A Expired FR2034539B1 (es) 1969-02-12 1970-02-11
FR7232347A Expired FR2154505B1 (es) 1969-02-12 1972-09-13

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7232347A Expired FR2154505B1 (es) 1969-02-12 1972-09-13

Country Status (10)

Country Link
AT (1) AT297024B (es)
BE (1) BE745047A (es)
CA (1) CA933522A (es)
CH (1) CH503051A (es)
DE (1) DE2006432A1 (es)
ES (1) ES376308A1 (es)
FR (2) FR2034539B1 (es)
GB (1) GB1236531A (es)
NL (1) NL146172B (es)
OA (1) OA03416A (es)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999053928A1 (en) * 1998-04-16 1999-10-28 University Of Manitoba Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
WO2000057863A2 (en) * 1999-03-25 2000-10-05 Medicure Inc. Use of pyridoxine compounds for treatment of cardiovascular and related pathologies
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759608A (fr) * 1970-01-08 1971-06-01 Soc D Etudes Prod Chimique Mono pyridoxal phosphate de papaverine, son procede de preparation ainsi que son utilisation therapeutique
IT1177061B (it) * 1984-10-26 1987-08-26 Lisapharma Spa Derivato salino farmacologicamente attivo del 3-idrossi-5-(idrossimetil)-2-metilisonicotinaldeide fosfato
JP2008517956A (ja) 2004-10-28 2008-05-29 メディキュア・インターナショナル・インコーポレーテッド 二重の抗血小板性／抗凝固性ピリドキシン類似体

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2828315A (en) * 1957-01-16 1958-03-25 Merck & Co Inc Procaine salt of pyridoxal phosphate and process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2828315A (en) * 1957-01-16 1958-03-25 Merck & Co Inc Procaine salt of pyridoxal phosphate and process

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999053928A1 (en) * 1998-04-16 1999-10-28 University Of Manitoba Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US7230009B2 (en) 1999-03-08 2007-06-12 Medicure, Inc. Pyridoxal analogues and methods of treatment
WO2000057863A2 (en) * 1999-03-25 2000-10-05 Medicure Inc. Use of pyridoxine compounds for treatment of cardiovascular and related pathologies
WO2000057863A3 (en) * 1999-03-25 2001-04-05 Medicure Inc Use of pyridoxine compounds for treatment of cardiovascular and related pathologies
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US7144892B2 (en) 1999-08-24 2006-12-05 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7132430B2 (en) 1999-08-24 2006-11-07 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7125889B2 (en) 1999-08-24 2006-10-24 Medicure International Inc. Treating of cardiovascular and related pathologies
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115626B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115625B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7148233B2 (en) 1999-08-24 2006-12-12 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7105673B2 (en) 2000-02-29 2006-09-12 Medicure International Inc. Cardioprotective phosphonates and malonates
US6867215B2 (en) 2000-02-29 2005-03-15 Medicure International Inc. Cardioprotective phosphonates and malonates
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6667315B2 (en) 2000-02-29 2003-12-23 Medicure International Inc. Cardioprotective phosphonates and malonates
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6861439B2 (en) 2000-03-28 2005-03-01 Medicure International, Inc. Treatment of cerebrovascular disease
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses

Also Published As

Publication number Publication date
CA933522A (en) 1973-09-11
BE745047A (fr) 1970-07-01
FR2154505B1 (es) 1976-03-05
FR2154505A1 (es) 1973-05-11
DE2006432A1 (es) 1970-12-03
NL7001348A (es) 1970-08-14
ES376308A1 (es) 1972-07-01
GB1236531A (en) 1971-06-23
FR2034539B1 (es) 1974-08-09
CH503051A (fr) 1971-02-15
OA03416A (fr) 1970-12-15
NL146172B (nl) 1975-06-16
AT297024B (de) 1972-03-10

Similar Documents

Publication Publication Date Title
AU465452B2 (es)
AU450150B2 (es)
AU442375B2 (es)
AU470301B1 (es)
AU5113869A (es)
AU442322B2 (es)
AU442535B2 (es)
AU442285B2 (es)
AU438128B2 (es)
AU442357B2 (es)
AU442380B2 (es)
AU442554B2 (es)
AU470661B1 (es)
AU442463B2 (es)
AU442538B2 (es)
AU4540468A (es)
AR203167Q (es)
AU4949169A (es)
AU5109569A (es)
AU5077469A (es)
BE755788A (es)
BE746782A (es)
AU4982068A (es)
AU4953367A (es)
AU5066368A (es)

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse